HMPC: overview of assessment work - priority list

Opinion/decision on a Paediatric investigation plan (PIP): Betmiga, Mirabegron, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0085/2024

EMEA-003170-PIP01-21-M02

Article 57 product data

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Mvabea, Ebola vaccine (MVA-BN-Filo [recombinant]), Date of authorisation: 01/07/2020, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Clopidogrel Krka, clopidogrel, Date of authorisation: 23/09/2009, Revision: 20, Status: Authorised

PMF dossier requirements - Questions and answers for PMF holders

Human medicines European public assessment report (EPAR): Zyllt, clopidogrel, Date of authorisation: 28/09/2009, Revision: 18, Status: Authorised

Agenda of the CAT meeting 14-16 May 2025